SCM
VRTX icon

Sio Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Sio Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-133,000
Closed -$34.7M – 78
2022
Q1 		$34.7M Buy
+133,000
New +$31.6M 11.48% 1

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sio Capital Management's VRTX Position: Q4 2021 in Review

Sio Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2021, closing a stake of 25,500 shares — an estimated $4.63M sold.

Sio Capital Management first reported a position in VRTX in Q1 2017 and held it in 9 quarters. The position peaked at $6.19M in Q4 2020. 1,034 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.

  • Sio Capital Management reported no remaining Vertex Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Sio Capital Management sold 25,500 Vertex Pharmaceuticals shares in Q4 2021, an estimated $4.63M.
  • Sio Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2017 and held it in 9 quarters.
  • Sio Capital Management's Vertex Pharmaceuticals position peaked at $6.19M in Q4 2020.
  • 1,034 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.

Based on Sio Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.